Articles producció científica> Medicina i Cirurgia

In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample

  • Datos identificativos

    Identificador: imarina:6388925
    Autores:
    Rodríguez-Balada MRoig BMartorell LMelé MSalvat MVilella EBorràs JGumà J
    Resumen:
    © 2016 Elsevier Inc. Ascertaining the clinical consequences of BRCA1 and BRCA2 variants of uncertain significance (VUS) is currently indispensable for providing effective genetic counseling and preventive actions for families with hereditary breast and ovarian cancer (HBOC). To this end, we conducted a combination of in silico prediction and cDNA splicing analyses of 13 BRCA1 and 10 BRCA2 VUS identified in our cohort as well as a case-control analysis in a population-based sample of 10 recurrent VUS. We observed consistent results between the in silico predictions and sequencing analyses for all analyzed VUS. An abnormal cDNA pattern was observed for variants c.212+1G>A and c.5278-1G>A in BRCA1 and c.516+2T>A and c.8168A>G in BRCA2 according to in silico splicing prediction. A case-control study of VUS confirmed the polymorphisms of the c.67+62A>G, c.7008-62A>G and c.8851G>A BRCA2 variants previously published. c.4068G>A in the BRCA2 gene can also be considered a polymorphism due to its occurrence at a frequency greater than 1% in our population. Our study shows that employing population-based analysis and a combination of several in silico methods yields highly accurate information, resulting in a reliable tool for selecting variants for cDNA sequencing analysis in routine cancer genetic counseling units.
  • Otros:

    Autor según el artículo: Rodríguez-Balada M; Roig B; Martorell L; Melé M; Salvat M; Vilella E; Borràs J; Gumà J
    Departamento: Medicina i Cirurgia
    Autor/es de la URV: BORRAS BALADA, JOAN LLUÍS / Gumà Padró, José / Martorell Bonet, Lourdes / RODRÍGUEZ BALADA, MARTA / Roig Bourgine, Barbara / Vilella Cuadrada, Elisabet
    Palabras clave: Variants of unknown significance Splicing Cdna Cancer genetic counseling Brca2 Brca1 splicing cdna cancer genetic counseling brca2 brca1
    Resumen: © 2016 Elsevier Inc. Ascertaining the clinical consequences of BRCA1 and BRCA2 variants of uncertain significance (VUS) is currently indispensable for providing effective genetic counseling and preventive actions for families with hereditary breast and ovarian cancer (HBOC). To this end, we conducted a combination of in silico prediction and cDNA splicing analyses of 13 BRCA1 and 10 BRCA2 VUS identified in our cohort as well as a case-control analysis in a population-based sample of 10 recurrent VUS. We observed consistent results between the in silico predictions and sequencing analyses for all analyzed VUS. An abnormal cDNA pattern was observed for variants c.212+1G>A and c.5278-1G>A in BRCA1 and c.516+2T>A and c.8168A>G in BRCA2 according to in silico splicing prediction. A case-control study of VUS confirmed the polymorphisms of the c.67+62A>G, c.7008-62A>G and c.8851G>A BRCA2 variants previously published. c.4068G>A in the BRCA2 gene can also be considered a polymorphism due to its occurrence at a frequency greater than 1% in our population. Our study shows that employing population-based analysis and a combination of several in silico methods yields highly accurate information, resulting in a reliable tool for selecting variants for cDNA sequencing analysis in routine cancer genetic counseling units.
    Áreas temáticas: Oncology Odontología Molecular biology Medicina iii Medicina ii Medicina i Genetics & heredity Genetics General medicine Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Cancer research Biotecnología Biodiversidade
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 22107762
    Direcció de correo del autor: lourdes.martorell@urv.cat elisabet.vilella@urv.cat barbara.roig@urv.cat jose.guma@urv.cat
    Identificador del autor: 0000-0003-4999-2197 0000-0002-1887-5919 0000-0001-7541-9832
    Fecha de alta del registro: 2024-09-07
    Versión del articulo depositado: info:eu-repo/semantics/acceptedVersion
    Enlace a la fuente original: https://www.cancergeneticsjournal.org/article/S2210-7762(16)30234-4/fulltext#%20
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referencia al articulo segun fuente origial: Cancer Genetics. 209 (11): 487-492
    Referencia de l'ítem segons les normes APA: Rodríguez-Balada M; Roig B; Martorell L; Melé M; Salvat M; Vilella E; Borràs J; Gumà J (2016). In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample. Cancer Genetics, 209(11), 487-492. DOI: 10.1016/j.cancergen.2016.09.003
    DOI del artículo: 10.1016/j.cancergen.2016.09.003
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2016
    Tipo de publicación: Journal Publications
  • Palabras clave:

    Cancer Research,Genetics,Genetics & Heredity,Molecular Biology,Oncology
    Variants of unknown significance
    Splicing
    Cdna
    Cancer genetic counseling
    Brca2
    Brca1
    splicing
    cdna
    cancer genetic counseling
    brca2
    brca1
    Oncology
    Odontología
    Molecular biology
    Medicina iii
    Medicina ii
    Medicina i
    Genetics & heredity
    Genetics
    General medicine
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Cancer research
    Biotecnología
    Biodiversidade
  • Documentos:

  • Cerca a google

    Search to google scholar